Skip to Main Content

The YODA ProjectThe YODA Project

    • Welcome
      • Policies
      • Development
      • Due Diligence Assessment
      • Data Use Agreement
      • Data Expiration
    • Project Leadership
    • Steering Committee
    • Roles & Responsibilities
      • Partnering with the YODA Project
        • Overview
        • Available Data
        • Data Release Pilot Project
      • Kenvue Brands LLC
        • Overview
        • Systematic Reviews
        • Approved Data Requests
      • QMUL
      • SI-BONE
    • Publications & Presentations
    • Announcements & Media Coverage
    • Relevant Literature
      • YODA Project Steering Committee and Stakeholders Conference
      • University College London and YODA Project Joint Meeting on Facilitating Data Access to Non-Industry Funded Research
    • Community Data Sharing Resources
    • FAQs
    • Acknowledgements
    • Contact Us
      • How To
      • Conflict of Interest
      • Data Use Agreement Training
    • Data Request Review Process
    • Request CSR Summary
    • Approved Data Requests
  • Trials
  • My Dashboard
    • YODA Project Metrics
      • Submitted Requests to Use Johnson & Johnson Data
      • Details of Data Requests
      • Clinical Trial Inquiries and CSR Summary Requests
      • Trials Determined to be Unavailable
  • Log in

Graft Versus Host Disease

NCT02959944 – Ibrutinib in Combination With Corticosteroids vs Placebo in Combination With Corticosteroids in Participants With New Onset Chronic Graft Versus Host Disease (cGVHD) (iNTEGRATE)

Posted on October 27, 2025 by Molly Willeford -

NCT02195869 – A Multicenter Open-Label Phase 1b/2 Study of Ibrutinib in Steroid Dependent or Refractory Chronic Graft Versus Host Disease

Posted on August 5, 2023 by tsuperadmin -

Side navigation

Site Map
Yale University logo
CORE - Center for outcomes, research, and evaluation Logo
  • Visit the YODA Project on Facebook
  • Visit the YODA Project on X

Accessibility at Yale

website designed by Gravity Switch